Periplasmic Targets for the Development of Effective Antimicrobials against Gram-Negative Bacteria. Academic Article uri icon

abstract

  • Antibiotic resistance has emerged as a serious threat to global public health in recent years. Lack of novel antimicrobials, especially new classes of compounds, further aggravates the situation. For Gram-negative bacteria, their double layered cell envelope and an array of efflux pumps act as formidable barriers for antimicrobials to penetrate. While cytoplasmic targets are hard to reach, proteins in the periplasm are clearly more accessible, as the drug only needs to breach the outer membrane. In this review, we summarized recent efforts on the validation and testing of periplasmic proteins as potential antimicrobial targets and the development of related inhibitors that either inhibit the growth of a bacterial pathogen or reduce its virulence during interaction with host cells. We conclude that the periplasm contains a promising pool of novel antimicrobial targets that should be scrutinized more closely for the development of effective treatment against multidrug-resistant Gram-negative bacteria.

published proceedings

  • ACS Infect Dis

altmetric score

  • 1.75

author list (cited authors)

  • Pandeya, A., Ojo, I., Alegun, O., & Wei, Y.

citation count

  • 20

complete list of authors

  • Pandeya, Ankit||Ojo, Isoiza||Alegun, Olaniyi||Wei, Yinan

publication date

  • September 2020